Becton Dickinson and Company

-6.42%

Becton Dickinson and Company (BD) is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD was founded in 1897 by Maxwell Becton and Fairleigh Dickinson and is headquartered in Franklin Lakes, New Jersey, USA.
The company's products are used in various healthcare settings such as hospitals, clinics, laboratories, and pharmacies, to improve patient care and help healthcare professionals diagnose and treat diseases. BD's main areas of focus include diagnostic systems, medication delivery solutions, and biosciences.
BD has a presence in over 190 countries and employs more than 70,000 people worldwide. The company has a global reach in both developed and emerging markets, with a diverse product portfolio and a strong research and development pipeline.
BD is committed to enhancing healthcare outcomes through innovation and collaboration with healthcare professionals, patients, and healthcare systems. The company aims to make a positive impact on the future of healthcare by providing safe, effective, and high-quality medical products and services.
In addition, BD has a strong commitment to corporate social responsibility and sustainability. The company focuses on initiatives related to improving access to healthcare, reducing its environmental footprint, and promoting ethical business practices.
Overall, BD is a leading company in the medical technology industry, with a long history of innovation and a strong dedication to improving healthcare outcomes globally.

1. Pioneering Medical Technology: Becton Dickinson (BD) is a global leader in medical technology, developing and manufacturing innovative medical devices, equipment, and diagnostic products. The company is known for its pioneering role in introducing many medical breakthroughs that have revolutionized healthcare.
2. Broad Product Portfolio: BD has a diverse portfolio of products that span the entire healthcare continuum, from medical devices to diagnostic solutions. The company's offering includes syringes, needles, IV catheters, infusion pumps, diabetes care products, molecular diagnostics, and more.
3. Global Presence: BD has a widespread global presence, with operations in over 50 countries and products sold in more than 190 countries. This allows the company to reach a vast customer base and provide healthcare solutions to people around the world.
4. Strong Focus on Innovation: BD invests heavily in research and development, with around $1.7 billion allocated for R&D in 2019. The company's commitment to innovation has resulted in numerous patents and groundbreaking products.
5. Commitment to Sustainability: BD takes a proactive approach to sustainability, implementing environmentally responsible practices in its operations and manufacturing processes. The company is also involved in various initiatives to reduce its carbon footprint and promote sustainable healthcare solutions.
6. Corporate Social Responsibility: BD has a strong corporate social responsibility (CSR) program, focusing on addressing global health challenges, improving healthcare access and outcomes, and promoting sustainable business practices.
7. Strong Financial Performance: BD has a history of delivering strong financial performance, with consistent revenue growth and a healthy balance sheet. This has helped the company to invest in research and development and expand its global presence.
8. Award-Winning Company: BD has received numerous accolades for its advancements in medical technology, commitment to sustainability, and corporate social responsibility. The company has been recognized by top publications and organizations, including Fortune, Forbes, and Corporate Responsibility Magazine.

Becton Dickinson and Company is a global medical technology company that specializes in the design, manufacture, and sale of medical devices, instrument systems, and reagents. The company's business model is focused on providing innovative and comprehensive solutions that improve patient outcomes and enhance healthcare provider efficiency.
The company operates in two main business segments: BD Medical and BD Life Sciences. The BD Medical segment offers a wide range of medical devices and systems used in hospitals, clinics, and other healthcare settings. These include syringes, needles, catheters, insulin pens, and infusion pumps.
The BD Life Sciences segment provides microbiology and molecular diagnostic products, as well as research and clinical tools used in drug discovery, biopharmaceutical manufacturing, and other life science research applications.
In addition to its product offerings, Becton Dickinson and Company also provides support services, including technical support, training, and consulting, to help customers optimize their use of the company's products.
The company's business model also includes a focus on sustainability and social responsibility, with efforts to reduce its environmental impact and improve access to healthcare in underserved communities.
Overall, Becton Dickinson and Company's business model is centered on innovation, quality, and efficiency, with a commitment to improving healthcare delivery and outcomes for patients worldwide.

1. Becton Dickinson and Company, also known as BD, is an American multinational medical technology company that was founded in 1897.
2. The company’s headquarters are located in Franklin Lakes, New Jersey.
3. BD is a leading global supplier of medical devices, instruments, and reagents for healthcare institutions, life science researchers, clinical laboratories, industry, and the general public.
4. The company has over 65,000 employees worldwide and operates in more than 50 countries.
5. BD is responsible for developing and producing many widely used medical devices, including syringes, insulin delivery systems, and blood collection and testing equipment.
6. BD was the first company to introduce a pre-filled syringe (BD Hypak) in 1990, revolutionizing the way drugs are administered.
7. In 1964, BD partnered with NASA to develop the first medical syringe that could be used in space. This led to the creation of the first safety syringe, which is now standard in healthcare facilities worldwide.
8. In 2017, BD acquired C.R. Bard, Inc., a leading manufacturer of medical devices for vascular, urology, and oncology procedures, for $24 billion.
9. BD’s products have been used in many significant medical advancements, including the first successful pancreas transplant in 1966 and the first successful in vitro fertilization in 1978.
10. The company has a long history of philanthropy and community involvement, including providing support for disaster relief efforts and providing free healthcare services to underserved communities.
11. BD has been named one of the World’s Most Ethical Companies by the Ethisphere Institute for 14 consecutive years.
12. The company has also been recognized for its commitment to diversity and inclusion, including being named one of the top companies for diversity by DiversityInc for nine consecutive years.
13. In 2020, BD was at the forefront of the global response to the COVID-19 pandemic, developing and distributing millions of testing kits and supplies for healthcare professionals.
14. The company has been listed on the Fortune 500 list consistently since 2011 and currently ranks at number 214.
15. BD continues to innovate and develop new technologies to improve healthcare outcomes and advance medical science. Their research and development pipeline includes over 4,000 patents.
See Company Due Diligence: